OCT 01, 2015 10:30 AM PDT

How the diagnosis of melanoma is made: clinical detection/recognition and histologic/genetic assessment

Speakers
  • Director of Dermatopathology (Dermatology), Associate Professor, Dermatology & Pathology, University of Colorado School of Medicine
    Biography
      Whitney A. High, MD, MEng, a native of Colorado, is the Director of the laboratory, and he is board-certified in Dermatology and Dermatopathology. He also has certification in Tropical Medicine & Hygiene. After practicing as a chemical engineer in industry, Dr. High returned to medical school to receive his medical degree from the Mayo Clinic School of Medicine in 2000. Dr. High completed his dermatology residency training at University of Texas Southwestern Medical Center in 2004, serving as Chief Resident, and his dermatopathology fellowship at the University of Colorado in Denver in 2005. He has also studied tropical medicine in Central and South America.

      Dr. High is appointed to the Departments of Dermatology & Pathology at the University of Colorado, and the Department of Chemistry at the Colorado School of Mines. He serves as the only dermatologist on faculty at the Denver STD/HIV Training Center, a clinic sponsored by the Centers for Disease Control (CDC). Dr. High also has a degree in law from the University of Denver.

      Dr. High has authored 2 textbooks, 12 chapters and more than 40 medical papers. He currently serves as one of the youngest editors of the Journal of the American Academy of Dermatology, and he is an editor/editorial board member of other medical journals.

    Abstract:

    The assessment of pigmented lesions is a difficult area of dermatology and dermatopathology.  Melanoma is the leading cause of cancer in woman age 25-29 years, yet it is also a leading cause of medicolegal suits against pathologists.  Much of the assessment of melanoma is subjective, and as of 2015, we do not yet have a singular diagnostic tool for melanoma, in routine use, that has greater than about 90% sensitivity.  In my short primer, in introductory fashion, we will discuss how the diagnosis of melanoma is rendered on clinical and histologic grounds. 
     


    Show Resources
    You May Also Like
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    Loading Comments...